GPC3 and hepatocellular carcinoma: In this regard, Ma X.H. et al. used iron oxide nanoparticles conjugated with double antibodies to target alpha-fetoprotein and glypican-3 (AFP and GPC3) antigens, which allows detection for the diagnosis of HCC [55].